Author:
Watanabe Susan M.,Simon Viviana,Durham Natasha D.,Kemp Brittney R.,Machihara Satoshi,Kemal Kimdar Sherefa,Shi Binshan,Foley Brian,Li Hongru,Chen Benjamin K.,Weiser Barbara,Burger Harold,Anastos Kathryn,Chen Chaoping,Carter Carol A.
Funder
NIH NIAID
National Institute of General Medical Sciences
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference48 articles.
1. Adamson CS, Sakalian M, Salzwedel K, Freed EO. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat. Retrovirology. 2010;7:36.
2. Lefebvre E, Schiffer CA. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. AIDS Rev. 2008;10:131–42.
3. Wensing AM, van Maarseveen NM, Nijhuis M. Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance. Antiviral Res. 2010;85:59–74.
4. Fun A, Wensing AM, Verheyen J, Nijhuis M. Human immunodeficiency virus Gag and protease: partners in resistance. Retrovirology. 2012;9:63.
5. Brumme ZL, Chan KJ, Dong WW, Wynhoven B, Mo T, Hogg RS, Montaner JS, O’Shaughnessy MV, Harrigan PR. Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy. Antivir Ther. 2003;8:91–6.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献